Shaw L J, Miller D D, Romeis J C, Younis L T, Gillespie K N, Kimmey J R, Chaitman B R
Department of Internal Medicine, Duke University Medical Center, Durham, NC 27705, USA.
J Am Geriatr Soc. 1996 Oct;44(10):1190-7. doi: 10.1111/j.1532-5415.1996.tb01368.x.
The purpose of this investigation is to explore the relationship of patient gender and age on coronary artery disease diagnostic evaluation and to assess the impact of noninvasive testing results on coronary revascularization rates and cardiac event-free survival.
Retrospective observational cohort.
From a series of 5322 consecutively tested patients from a Midwestern university tertiary medical center, a hospital cohort of 1345 patients with clinically suspected coronary artery disease was enrolled from 1988 through 1989.
Cardiac risk factor and symptom profiles were worse in women, whereas rates of positive test results were similar in both sexes. Multivariable-adjusted risk for follow-up diagnostic testing was 1.8 and 1.9 times greater, respectively, for men < or = and > 65 years of age than for women (P < .01). Younger women were 4.9 times (P = .001) more likely to experience a cardiac event than younger men, with no differences between younger and older women (relative risk = 1.1; P > .20). Overall cardiac event rates were 2.3, 7.4, 16.7, and 20.2% for young men, young women, older women, and older men, respectively. Initial screening was delayed 2 to 7 times longer for older and younger women compared with men (P < .001); the greatest delays were observed for younger women. Diagnostic follow-up and subsequent cost of total care from initial evaluation through 2 years of follow-up were higher for men than for women (P < .0001), with older women having the lowest rate of subsequent diagnostic and interventional follow-up. In the highest risk patients, subsequent utilization rates were 40 and 20% higher for younger and older men than for similarly aged women. In particular, diabetics were less likely to undergo follow-up diagnostic testing and revascularization (67% younger women).
Age appears to significantly and differently influence decisions regarding noninvasive and invasive medical service utilization in men and women and may partially account for variable outcomes in this and previous gender-based comparisons.
本研究旨在探讨患者性别和年龄与冠心病诊断评估之间的关系,并评估无创检测结果对冠状动脉血运重建率和无心脏事件生存率的影响。
回顾性观察队列研究。
从一所中西部大学三级医疗中心连续检测的5322例患者中,选取了1988年至1989年期间1345例临床疑似冠心病的住院患者作为研究队列。
女性患者的心脏危险因素和症状特征更差,而两性的检测阳性率相似。年龄≤65岁和>65岁男性的多变量调整后随访诊断检测风险分别是女性的1.8倍和1.9倍(P<0.01)。年轻女性发生心脏事件的可能性是年轻男性的4.9倍(P = 0.001),年轻女性和老年女性之间无差异(相对风险 = 1.1;P>0.20)。年轻男性、年轻女性、老年女性和老年男性的总体心脏事件发生率分别为2.3%、7.4%、16.7%和20.2%。与男性相比,老年和年轻女性的初始筛查延迟时间长2至7倍(P<0.001);年轻女性的延迟时间最长。从初始评估到2年随访期间,男性的诊断随访及后续总护理费用高于女性(P<0.0001),老年女性的后续诊断和介入随访率最低。在高危患者中,年轻和老年男性的后续利用率比同龄女性高分别40%和20%。特别是糖尿病患者接受随访诊断检测和血运重建的可能性较小(年轻女性为67%)。
年龄似乎对男性和女性关于无创和有创医疗服务利用的决策有显著且不同的影响,这可能部分解释了本次及以往基于性别的比较中不同的结果。